The city of Rochester, Minnesota, currently has 3 active clinical trials seeking participants for NASH - Nonalcoholic Steatohepatitis research studies.
Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects
Recruiting
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
05/13/2024
Locations: Mayo Clinic Rochester, Rochester, Minnesota
Conditions: NASH - Nonalcoholic Steatohepatitis
Statins for the Treatment of NASH
Recruiting
The purpose of this research study is to determine whether the study drug, atorvastatin (LipitorĀ®), is safe and effective in improving the features of NASH.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
04/08/2024
Locations: Mayo Clinic Minnesota, Rochester, Minnesota
Conditions: NASH - Nonalcoholic Steatohepatitis
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Recruiting
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Gender:
All
Ages:
18 years and above
Trial Updated:
01/24/2024
Locations: Mayo Clinic - Rochester, Rochester, Minnesota
Conditions: NASH - Nonalcoholic Steatohepatitis